Google collecting personal data of millions in health project

Amy Baxter | | Health Exec | Digital Transformation

Google is collecting one of the biggest troves of personal data in its healthcare initiative, known as “Project Nightingale,” with detailed information of millions of Americans, according to The Wall Street Journal.

Google has acquired the personal health information of millions by teaming up with one of the nation’s largest health systems, Ascension––and they’re keeping the project secret. Project Nightingale launched last year, and neither patient nor doctors have been notified that complete health histories––including patient names and dates of birth––have been collected, the WSJ reported.

The revelation by the news outlet brings patient privacy into a new light, as Google is using the information to build new software, but privacy laws under the Health Insurance Portability and Accountability Act (HIPAA) allow healthcare organizations to share patient data if it helps carry out their healthcare functions. And patients don’t have to be notified under HIPAA if their information is shared for those purposes.

The WSJ’s report also could put Amazon, Apple and Microsoft on notice, as they also continue to invest further in the healthcare space to make headway with critical healthcare data.

See the full story below:

Google’s Secret ‘Project Nightingale’ Gathers Personal Health Data on Millions …

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

To tell or not to tell: Do patients really need to know who—or what—writes their doctor’s notes?
5 ways AI can help make healthcare more affordable for everyone
HIMSS survey report: Beware insider threats to cybersecurity involving AI
Primary care is primed for AI. But is AI aligned with primary care?
Machine learning vs. bodily pain: 5 points of promise and challenge
Generative AI isn’t changing everything for patients and providers—but it’s not leaving much unaffected, either

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.